Details of the Drug

General Information of Drug (ID: DM9LXTJ)

Drug Name

ATA230

Synonyms

adimlecleucel

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Clinical trial	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03010332) An Expanded Access Protocol of ATA230 (Third-Party Donor-Derived Cytomegalovirus-Specific T Cells) for the Treatment of CMV Viremia or Disease in Subjects for Whom There Are No Other Comparable Options. U.S.National Institutes of Health.